Implantable cardioverter defibrillator (ICD) implantation carries a significant risk of
complications, however published estimates appear inconsistent. We aimed to present a …

Implantable cardioverter-defibrillator (ICD) therapy is clearly an effective therapy for selected
patients in definable populations. The benefits and risks of ICD therapy are directly impacted …

Multiple randomized multicentre clinical trials have established the role of the implantable
cardioverter-defibrillator (ICD) as the mainstay in the treatment of ventricular …

The implantable cardioverter defibrillator (ICD) has emerged as an important treatment
option for selected patients who are at risk of sudden cardiac death. Randomized trials have …

Objectives: The aim of this study was to compare single-versus dual-chamber implantable
cardioverter-defibrillator (ICD) implantation and complication rates in a large, real-world …

Sudden cardiac death is a major public health issue in Canada. However, despite the
overwhelming evidence to support the use of implantable cardioverter defibrillators (ICDs) in …

Importance Randomized trials of implantable cardioverter-defibrillators (ICDs) for primary
prevention predominantly used single-chamber devices. In clinical practice, patients often …

Background Routine addition of an atrial lead during an implantable cardioverter‐
defibrillator (ICD) implantation for primary prevention of sudden cardiac death, in patients …

Implantable cardioverter-defibrillators (ICDs) reduce sudden cardiac death risk and improve
survival in patients with a history of life-threatening arrhythmia or cardiac arrest (secondary …

Abstract Aims Single-chamber (VR-ICD) and subcutaneous (S-ICD) implantable cardioverter-
defibrillators are effective to protect patients against sudden death but expose them to higher …